# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-107983
Filing Date
2025-08-13
Accepted
2025-08-13 16:00:58
Documents
69
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgvn-20250630.htm iXBRL | 10-Q | 2450819
2 | EX-31.1 | lgvn-ex31_1.htm | EX-31.1 | 14829
3 | EX-31.2 | lgvn-ex31_2.htm | EX-31.2 | 14876
4 | EX-32.1 | lgvn-ex32_1.htm | EX-32.1 | 13532
5 | GRAPHIC | img238713470_0.jpg | GRAPHIC | 21270
| Complete submission text file | 0000950170-25-107983.txt |  | 9634936

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | lgvn-20250630.xsd | EX-101.SCH | 1279648
72 | EXTRACTED XBRL INSTANCE DOCUMENT | lgvn-20250630_htm.xml | XML | 1553628

Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40060 | Film No.: 251211281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)